Lea Fuchs
Overview
Explore the profile of Lea Fuchs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vayena E, Fuchs L, Peyhani H, Lagoda K, Nguyen B, Hardt W, et al.
PLoS Comput Biol
. 2025 Mar;
21(3):e1012869.
PMID: 40067815
Nontyphoidal Salmonella strains (NTS) are among the most common foodborne enteropathogens and constitute a major cause of global morbidity and mortality, imposing a substantial burden on global health. The increasing...
2.
Laganenka L, Lee J, Malfertheiner L, Dieterich C, Fuchs L, Piel J, et al.
Nat Microbiol
. 2023 Jan;
8(2):204-217.
PMID: 36624229
Bacteria communicate and coordinate their behaviour at the intra- and interspecies levels by producing and sensing diverse extracellular small molecules called autoinducers. Autoinducer 2 (AI-2) is produced and detected by...
3.
Nguyen B, Cuenca V M, Hartl J, Gul E, Bauer R, Meile S, et al.
Cell Host Microbe
. 2020 May;
27(6):922-936.e6.
PMID: 32416061
Initial enteropathogen growth in the microbiota-colonized gut is poorly understood. Salmonella Typhimurium is metabolically adaptable and can harvest energy by anaerobic respiration using microbiota-derived hydrogen (H) as an electron donor...
4.
Putter K, van Deenen N, Muller B, Fuchs L, Vorwerk K, Unland K, et al.
Sci Rep
. 2019 Apr;
9(1):5942.
PMID: 30976052
Only very little is known about the resin composition of natural rubber from the dandelion species Taraxacum koksaghyz, thus its full characterization could provide new insights into how the isoprenoid...
5.
Robert N, Leyland-Jones B, Asmar L, Belt R, Ilegbodu D, Loesch D, et al.
J Clin Oncol
. 2006 Jun;
24(18):2786-92.
PMID: 16782917
Purpose: This randomized, multicenter, phase III trial evaluated the efficacy and safety of trastuzumab and paclitaxel with or without carboplatin as first-line therapy for women with HER-2-overexpressing metastatic breast cancer...